Determination of phthalates in beverages using multiwalled carbon nanotubes dispersive solid-phase extraction before HPLC-MS.

A microdispersive solid-phase extraction method has been developed using multiwalled carbon nanotubes of 110-170 nm diameter and 5-9 µm length for the extraction of a group of nine phthalic acid esters (i.e., bis(2-methoxyethyl) phthalate, bis-2-ethoxyethyl phthalate, dipropyl phthalate, butylbenzyl phthalate, bis-2-n-butoxyethyl phthalate, bis-isopentyl phthalate, bis-n-pentyl phthalate, dicyclohexyl phthalate, and di-n-octyl phthalate) from tap water as well as from different beverages commercialized in plastic bottles (mineral water, lemon- and apple-flavored mineral water, and an isotonic drink). Determination was carried out by high-performance liquid chromatography coupled to mass spectrometry. The extraction procedure was optimized following a step-by-step approach, being the optimum extraction conditions: 50 mL of each sample at pH 6.0, 80 mg of sorbent, and 25 mL of acetonitrile as elution solvent. To validate the methodology, matrix-matched calibration and a recovery study were developed, obtaining determination coefficients >0.9906 and absolute recovery values between 70 and 117% (with relative standard deviations < 17%) in all cases. The limits of quantification of the method were between 0.173 and 1.45 µg/L. After the evaluation of the matrix effects, real samples were also analyzed, finding butylbenzyl phthalate in all samples (except in apple-flavored mineral water), though at concentrations below its limit of quantification of the method.

Synthesis and pharmacological activity of diterpenylnaphthoquinone derivatives.

New diterpenylquinones, combining a diterpene diacid and a naphthoquinone, were prepared from junicedric acid and lapachol. The new derivatives were assessed as gastroprotective agents by the HCl-EtOH-induced gastric lesions model in mice as well as for basal cytotoxicity on the following human cell lines: Normal lung fibroblasts (MRC-5), gastric epithelial adenocarcinoma (AGS), and hepatocellular carcinoma (Hep G2). Several of the new compounds were significantly active as antiulcer agents and showed selective cytotoxicity against AGS cells.